The clinical relevance of our experimental findings was supported by immunohistochemical staining analyses demonstrating that the expression of HDAC7, ITGB1, LGALS3 and CD44 was highest in GBM tumours and was negatively correlated with SOX8 expression (Figure 6A, B). The gene discussed is HDAC7; the disease is glioblastoma.